Follistatin
From Proteopedia
(Difference between revisions)
| Line 25: | Line 25: | ||
**[[5jhw]] - hFs1 + GDF-11 - human<br /> | **[[5jhw]] - hFs1 + GDF-11 - human<br /> | ||
| - | **[[2p6a]], [[2b0u]] - hFs1 + | + | **[[2p6a]], [[2b0u]] - hFs1 + activin<br /> |
**[[3hh2]] - hFs1 + myostatin<br /> | **[[3hh2]] - hFs1 + myostatin<br /> | ||
**[[1lr9]] - rFs1 heparin-binding domain 93-165 - rat<br /> | **[[1lr9]] - rFs1 heparin-binding domain 93-165 - rat<br /> | ||
| - | **[[2arp]] - rFs1 + | + | **[[2arp]] - rFs1 + activin<br /> |
**[[1lr8]], [[1lr7]] - rFs1 heparin-binding domain + heparin analog<br /> | **[[1lr8]], [[1lr7]] - rFs1 heparin-binding domain + heparin analog<br /> | ||
| Line 35: | Line 35: | ||
**[[3sek]] - hFstl-1 residues 36-244 + myostatin<br /> | **[[3sek]] - hFstl-1 residues 36-244 + myostatin<br /> | ||
**[[2kcx]] - hFstl-3 Kazal-1 domain - NMR<br /> | **[[2kcx]] - hFstl-3 Kazal-1 domain - NMR<br /> | ||
| - | **[[3b4v]] - hFstl-3 residues 27-263 + | + | **[[3b4v]] - hFstl-3 residues 27-263 + activin<br /> |
**[[6jza]] - mFstl-1 residues 20-93 - mouse<br /> | **[[6jza]] - mFstl-1 residues 20-93 - mouse<br /> | ||
}} | }} | ||
Revision as of 06:52, 21 May 2020
| |||||||||||
3D structures of follistatin
Updated on 21-May-2020
References
- ↑ Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol. 1998 Oct;19(4):287-322. doi: 10.1006/frne.1998.0169. PMID:9799587 doi:http://dx.doi.org/10.1006/frne.1998.0169
- ↑ Tortoriello DV, Sidis Y, Holtzman DA, Holmes WE, Schneyer AL. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology. 2001 Aug;142(8):3426-34. PMID:11459787
- ↑ Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER. Regulation of muscle mass by follistatin and activins. Mol Endocrinol. 2010 Oct;24(10):1998-2008. doi: 10.1210/me.2010-0127. Epub 2010, Sep 1. PMID:20810712 doi:http://dx.doi.org/10.1210/me.2010-0127
- ↑ Ogura Y, Ouchi N, Ohashi K, Shibata R, Kataoka Y, Kambara T, Kito T, Maruyama S, Yuasa D, Matsuo K, Enomoto T, Uemura Y, Miyabe M, Ishii M, Yamamoto T, Shimizu Y, Walsh K, Murohara T. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation. 2012 Oct 2;126(14):1728-38. doi: 10.1161/CIRCULATIONAHA.112.115089. , Epub 2012 Aug 28. PMID:22929303 doi:http://dx.doi.org/10.1161/CIRCULATIONAHA.112.115089
